Mycophenolate Mofetil and Cyclophosphamide Treatments Suppress Inflammation Intensity in an Experimental Model of Autoimmune Uveitis

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10282076" target="_blank" >RIV/00216208:11110/14:10282076 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/14:10282076
Result on the web
<a href="http://fb.cuni.cz/file/5756/fb2014a0043.pdf" target="_blank" >http://fb.cuni.cz/file/5756/fb2014a0043.pdf</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Mycophenolate Mofetil and Cyclophosphamide Treatments Suppress Inflammation Intensity in an Experimental Model of Autoimmune Uveitis
Original language description
In human autoimmune uveitis is a leading cause of visual disability and ranks with diabetic retinopathy as a major source of blind registrations in developed countries. Since most cases of non.infectious uveitis are considered to be autoimmune or at least immune-mediated,the management of such patients has rested on appropriate immunosupressions.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry
OECD FORD branch
—

Project
<a href="/en/project/NT14017" target="_blank" >NT14017: The Role of Microorganisms in the Process of Autoimmune Uveitis</a><br>
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)